Advertisement

Pharmacological Management of the Neuropathic Bladder and Urethra

  • Ananias C. Diokno
  • L. Paul Sonda
Part of the Clinical Practice in Urology book series (PRACTICE UROLOG)

Abstract

The demand upon physicians to treat a growing number of patients with neuropathic bladder and urethra can be traced to a variety of reasons. The improved emergency services and intensive care provided for trauma victims have resulted in an increased survival of patients, many of whom have spinal cord and peripheral nerve injury. Additionally, the increased use of newer diagnostic equipment and an increased index of suspicion for neuropathic bladder disorders have improved our ability to recognise these problems. Extensive dissemination of new information pertaining to neurogenic bladder and sphincter dysfunctions has thrust the problem into a more prominent position in modern medical practice.

Keywords

Pudendal Nerve External Sphincter Neurogenic Bladder Detrusor Contraction Cholinergic Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andersson K-E, Ek A, Hedlund H, Mattiasson A (1981) Effects of prazosin on isolated human urethra and in patients with lower motor neuron lesions. Invest Urol 19: 39–42PubMedGoogle Scholar
  2. Awad SA, Bruce AW, Carro-Ciampi G, Downie JW, Lin M (1974) Distribution of alpha and beta adrenoceptors in human urinary bladder. Br J Pharmacol 50: 525–529PubMedGoogle Scholar
  3. Awad SA, Bryniak S, Downie JW, Bruce AW (1977) The treatment of the uninhibited bladder with dicyclomine. J Urol 117: 161–163PubMedGoogle Scholar
  4. Awad SA, Downie JW, Kiruluta HG (1978) Alpha-adrenergic agents in urinary disorders of the proximal urethra. II. Urethral obstruction due to ‘sympathetic dyssynergia’. Br J Urol 50: 336–339PubMedCrossRefGoogle Scholar
  5. Cannon WB, Rosenbleuth A (1949) The supersensitivity of denervated structures. Macmillan, New YorkGoogle Scholar
  6. Diokno AC, Koppenhoefer R (1976) Bethanechol chloride in neurogenic bladder dysfunction. Urology 8: 455–458PubMedCrossRefGoogle Scholar
  7. Diokno AC, Lapides J (1972) Oxybutynin, a new drug with analgesic and anticholinergic properties. J Urol 108: 307–309PubMedGoogle Scholar
  8. Diokno AC, Taub M (1975) Ephedrine in the treatment of urinary incontinence. Urology 5: 624–625PubMedCrossRefGoogle Scholar
  9. Diokno AC, Koff SA, Bender LF (1974) Periurethral striated muscle activity in neurogenic bladder dysfunction. J Urol 112: 743–749PubMedGoogle Scholar
  10. Diokno AC, Davis R, Lapides J (1975) Urecholine test for denervated bladders. Invest Urol 13: 233–235Google Scholar
  11. Finkbeiner AE, Bissada NK (1980) Drug therapy for lower urinary tract dysfunction. Urol Clin North Am 7: 3–16PubMedGoogle Scholar
  12. Fischer CP, Diokno AC, Lapides J (1978) The anticholinergic effects of dicyclomine hydrochloride in uninhibited neurogenic bladder dysfunction. J Urol 120: 328–329PubMedGoogle Scholar
  13. Gosling JA, Dixon JS (1979) Light and electron microscopic observations on the human external urethral sphincter. J Anat 129: 216Google Scholar
  14. Gosling JA, Dixon JS, Critchley HOD, Thompson SA (1981) A comparative study of the human external sphincter and periurethral levator ani muscles. Br J Urol 53: 35–41PubMedCrossRefGoogle Scholar
  15. Khanna OP (1976) Disorders of micturition: neuropharmacologic basis and results of drug therapy. Urology 8: 316–328PubMedCrossRefGoogle Scholar
  16. Khanna OP, Gonick P (1975) Effects of phenoxybenzamine hydrochloride on canine lower urinary tract: clinical implication. Urology 6: 323–330PubMedCrossRefGoogle Scholar
  17. Kieswetter H, Popper L (1972) A cystometrographic study to assess the influence of atropine, propantheline and mebeverine on the smooth muscle of the bladder. Br J Urol 44: 31–35PubMedCrossRefGoogle Scholar
  18. Koff SA, Lapides, J, Piazza DH (1979) The uninhibited bladder in children: a cause for urinary obstruction, infection, and reflux. In: Hodson J, Kincaid-Smith P (eds) Reflux nephropathy. Masson Publishing, New York, pp 161–169Google Scholar
  19. Koyanagi T, Tsuji I (1978) Reappraisal of the sympathetic role in the sphincteric urethra. Denervation supersensitivity of the urethra of the chronic neurogenic bladder to alpha-adrenergic drugs. Invest Urol 15: 267–269PubMedGoogle Scholar
  20. Krane RJ, Olsson CA (1973) Phenoxybenzamine in neurogenic bladder dysfunction. II. Clinical considerations. J Urol 110: 653–656PubMedGoogle Scholar
  21. Lapides J, Diokno AC (1976) Urine transport, storage and micturition. In: Lapides J (ed) Fundamental of urology. WB Saunders, Philadelphia, pp 190–241Google Scholar
  22. Lapides J, Friend CR, Ajemian EP, Reus WS (1962) Denervation supersensitivity as a test for neurogenic bladder. Surg Gynecol Obstet 114: 241–244Google Scholar
  23. Leyson JFJ, Martin BF, Sporer A (1980) Baclofen in the Treatment of detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 124: 82–84PubMedGoogle Scholar
  24. MacGregor RJ, Diokno AC (1981) The alpha-adrenergic blocking action of prazosin hydrochloride on the canine urethra. Invest Urol 18: 426–429PubMedGoogle Scholar
  25. Murdock MM, Sax D, Krane RJ (1976) Use of dantrolene sodium in external sphincter spasm. Urology 8: 133–137PubMedCrossRefGoogle Scholar
  26. Pedersen E, Harving H, Klemar B (1978) Effect of dantrolene sodium on the spastic external urethral sphincter recorded by sphincterometry. J Urol 119: 403–405PubMedGoogle Scholar
  27. Perlow DL, Diokno AC (1980) Cystometric and perineal electromyography in spinal cord-injured patients. Urology 15: 432–433PubMedCrossRefGoogle Scholar
  28. Piazza DH, Diokno AC (1979) Review of neurogenic bladder in multiple sclerosis. Urology 14: 33–35PubMedCrossRefGoogle Scholar
  29. Pinder RM, Brogden RN, Speight TM, Avery GS (1977) Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity. Drugs 13: 3–23PubMedCrossRefGoogle Scholar
  30. Raz S, Bradley WE (1979) Neuromuscular dysfunction of the lower urinary tract. In: Harrison JH et a1. (eds) Urology, 4th edn. WB Saunders, Philadelphia, pp 1215–1270Google Scholar
  31. Smey P, Firlit CF, King LR (1978) Voiding pattern abnormalities in normal children: results of pharmacologic manipulation. J Urol 120: 574–577PubMedGoogle Scholar
  32. Sonda LP, Gershon C, Diokno AC, Lapides J (1979) Further observations on the cystometric and uroflowmetric effects of bethanechol chloride on the human bladder. J Urol 122: 775–777PubMedGoogle Scholar
  33. Sporer A, Leyson JFJ, Martin BF (1978) Effects of bethanechol chloride on the external urethral sphincter in spinal cord injury patients. J Urol 120: 62–66PubMedGoogle Scholar
  34. Stewart BR, Banowsky LHW, Montague DK (1976) Stress incontinence: conservative therapy with sympathomimetic drugs. J Urol 115: 558–559PubMedGoogle Scholar
  35. Thompson IM, Lauvetz R (1976) Oxybutynin in bladder spasm, neurogenic bladder and enuresis. Urology 8: 452–454PubMedCrossRefGoogle Scholar
  36. Vaidyanathan A, Rao MS, Mapa MK, Bapna BC, Chary KSN, Swamy RP (1981) Study of intravesical instillation of 15-(5)-15 methyl prostaglandin F in patients with neurogenic bladder dysfunction. J Urol 126: 81–85PubMedGoogle Scholar
  37. Vinson RK, Diokno AC (1976) Uninhibited neurogenic bladder in adults. Urology 7: 376–378PubMedCrossRefGoogle Scholar
  38. Yalla SV, Rossier AB, Fam B (1976) Dyssynergic vesicourethral responses during bladder rehabilitation in spinal cord injury patients: effects of suprapubic percussion, Credé method and bethanechol chloride. J Urol 115: 575–579PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • Ananias C. Diokno
  • L. Paul Sonda

There are no affiliations available

Personalised recommendations